Skip to main content
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.710
-0.270 (-9.06%)
At close: Dec 20, 2024, 4:00 PM
2.660
-0.050 (-1.85%)
After-hours: Dec 20, 2024, 4:30 PM EST

Daré Bioscience Revenue

Daré Bioscience had revenue of $41.69K in the quarter ending September 30, 2024, a decrease of -95.83%. This brings the company's revenue in the last twelve months to $1.88M, up 88.13% year-over-year. In the year 2023, Daré Bioscience had annual revenue of $2.81M, down -71.92%.

Revenue (ttm)
$1.88M
Revenue Growth
+88.13%
P/S Ratio
11.98
Revenue / Employee
$72,358
Employees
26
Market Cap
23.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.81M-7.19M-71.92%
Dec 31, 202210.00M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HOOKIPA Pharma 50.00M
DarioHealth 23.05M
Curis 10.26M
LAVA Therapeutics 7.35M
Femasys 1.26M
Gelteq 95.62K
Revenue Rankings

DARE News

More News